Note 5. Segment Reporting (Segments Statements of Operations) (Details) (USD $)	3 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Segment Reporting Information [Line Items]
Product revenue	$ 2,269,577	$ 2,406,580
Revenues, net	2,269,577	2,406,580
Cost of goods sold	1,196,398	1,224,428
Marketing, general and administrative	1,405,586	1,381,882
Research and development	264,198	219,551
Total costs and expenses	2,866,182	2,825,861
Loss from operations	(596,605)	(419,281)
Gain (Loss) Related to Litigation Settlement	63,589	0
Equity in OTM	1,192	699
Interest income	24	43
Interest Expense	(92,596)	(82,491)
Total other (expense) income	(27,791)	(81,749)
(Loss) and income before taxes	(624,396)	(501,030)
Income taxes benefit from continuing operations	0	0
Net (loss) from continuing operations	(624,396)	(501,030)
Sonomed-Escalon [Member]
Segment Reporting Information [Line Items]
Product revenue	2,269,577	2,406,580
Revenues, net	2,270,000	2,407,000
Cost of goods sold	1,196,398	1,224,428
Marketing, general and administrative	964,440	885,785
Research and development	264,198	219,551
Total costs and expenses	2,424,000	2,330,000
Loss from operations	(154,000)	77,000
Gain (Loss) Related to Litigation Settlement	0	0
Equity in OTM	0	0
Interest Expense	0	0
Total other (expense) income	0	0
(Loss) and income before taxes	(155,459)	76,816
Income taxes benefit from continuing operations	0	0
Net (loss) from continuing operations	(155,459)	76,816
Corporate [Member]
Segment Reporting Information [Line Items]
Product revenue	0	0
Revenues, net	0	0
Cost of goods sold	0	0
Marketing, general and administrative	441,146	496,097
Research and development	0	0
Total costs and expenses	441,000	496,000
Loss from operations	(441,000)	(496,000)
Gain (Loss) Related to Litigation Settlement	63,589	0
Equity in OTM	1,192	699
Interest Expense	(92,596)	(82,491)
Total other (expense) income	(27,791)	(81,749)
(Loss) and income before taxes	(468,937)	(577,846)
Income taxes benefit from continuing operations	0	0
Net (loss) from continuing operations	$ (468,937)	$ (577,846)